Source: ACTA GASTROENTEROLOGICA LATINOAMERICANA. Unidade: FM
Subjects: NEOPLASIAS GÁSTRICAS, CARCINOMA HEPATOCELULAR, MODELOS ANIMAIS, PREVENÇÃO DE DOENÇAS
ABNT
FERRARI, J. Tonin et al. Potential beneficial effect of rifaximin in the prevention of hepatocellular carcinoma through the modulation of the microbiota in an experimental model of non-alcoholic fatty liver disease. ACTA GASTROENTEROLOGICA LATINOAMERICANA, v. 53, n. 3, p. 265-282, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58621. Acesso em: 09 nov. 2024.APA
Ferrari, J. T., Guerreiro, G. T. S., Longo, L., Silveira, T. R. D., Cerski, C. T. S., Tozawa, E., et al. (2023). Potential beneficial effect of rifaximin in the prevention of hepatocellular carcinoma through the modulation of the microbiota in an experimental model of non-alcoholic fatty liver disease. ACTA GASTROENTEROLOGICA LATINOAMERICANA, 53( 3), 265-282. doi:10.52787/agl.v53i3.329NLM
Ferrari JT, Guerreiro GTS, Longo L, Silveira TRD, Cerski CTS, Tozawa E, Oliveira CP, Álvares-da-Silva MR, Uribe-Cruz C. Potential beneficial effect of rifaximin in the prevention of hepatocellular carcinoma through the modulation of the microbiota in an experimental model of non-alcoholic fatty liver disease [Internet]. ACTA GASTROENTEROLOGICA LATINOAMERICANA. 2023 ; 53( 3): 265-282.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58621Vancouver
Ferrari JT, Guerreiro GTS, Longo L, Silveira TRD, Cerski CTS, Tozawa E, Oliveira CP, Álvares-da-Silva MR, Uribe-Cruz C. Potential beneficial effect of rifaximin in the prevention of hepatocellular carcinoma through the modulation of the microbiota in an experimental model of non-alcoholic fatty liver disease [Internet]. ACTA GASTROENTEROLOGICA LATINOAMERICANA. 2023 ; 53( 3): 265-282.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58621